Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
17985
Title:
Update recommendations on Human Papillomavirus (HPV) vaccine: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations
Fulltext:
View HTML (primary care)
Also available:
Français
Author
Tunis MC, Ismail S, Deeks SL
Publication/Review date:
2017-May 
Producers:
National Advisory Committee on Immunization

Bibliographic Source

Place of Publication:
Ottawa
Publisher(s):
Public Health Agency of Canada
Date Accessed:
2018-01-15
Pages/Size:
31  Page(s)
References:
18

Subject Information

Specialties:
Community and preventive medicine, Infectious diseases, Family practice,
Conditions:
HPV Infection;
Domains:
Preventive
Target Populations:
Child, Adolescent, Adult
Target Gender:
Unknown
MeSH:
epidemiology ; Immunocompromised Host; Papillomavirus Vaccines ; HIV Infections; Papillomavirus Infections; Immunization;

Copyright:

The copyright of this guideline and its companion documents belongs to: Public Health Agency of Canada

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​